ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

CCOP Q&A, List Of Research Bases

September 10, 1982

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

October 14, 2005

I-131 doses highest Near Nevada Test Site, Fallout Study Finds

November 17, 1989

Chart Show 1980 Budget Breakown By Mechanisms, Research Programs, Compare Them With Previous Years

June 9, 1978

HHS bans tobacco from its campuses, opens national quitline, 1-800-QUITNOW.

November 19, 2004

Clinical Oncology Program Has Top Priority Fink Says

February 9, 1979